These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 743381)

  • 1. [Glisolamide, a new sulfanylurea. Pharmacologic characteristics].
    D'Alò G; Dalla Vedova R; Cadel S; Campi G; Wassermann A
    Boll Chim Farm; 1978 Jun; 117(6):348-67. PubMed ID: 743381
    [No Abstract]   [Full Text] [Related]  

  • 2. [The toxicology of glisoxepide, a new oral antidiabetic. Results of animal studies].
    Tettenborn D
    Arzneimittelforschung; 1974 Mar; 24(0):409-18. PubMed ID: 4408138
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study of the protective activity of glisolamide on experimental atherosclerosis in the rabbit].
    Dalla Vedova R; Cadel S; D'Alò G
    G Clin Med; 1979 Nov; 60(11):911-26. PubMed ID: 546672
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effectiveness, toxicity and action of new hypoglycemic agents].
    Wójcikowski C
    Pol Tyg Lek; 1978 Oct; 33(40):1583-4. PubMed ID: 704465
    [No Abstract]   [Full Text] [Related]  

  • 5. Glypentide: a new hypoglycaemic agent.
    Morell J
    Biochem Pharmacol; 1974 Oct; 23(20):2922-4. PubMed ID: 4429592
    [No Abstract]   [Full Text] [Related]  

  • 6. [In vitro effect of glysolamide on blood coagulation].
    Dalla Vedova R; Cadel S; Wassermann A
    Boll Chim Farm; 1979 Jan; 118(1):28-30. PubMed ID: 454528
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacokinetic study in the rat of a new hypoglycemic agent: glisolamide].
    Cerri L; Dalla Vedova R; Groppetti A
    G Clin Med; 1979 Nov; 60(11):903-10. PubMed ID: 546671
    [No Abstract]   [Full Text] [Related]  

  • 8. The pharmacology S 1702, a new highly effective oral antidiabetic drug with unusual properties. 3. Antistickiness activity, fibrinolytic properties and haemostatic parameters study.
    Desnoyers P; Labaume J; Anstett M; Herrera M; Pesquet J; Sebastien J
    Arzneimittelforschung; 1972 Oct; 22(10):1691-5. PubMed ID: 4677058
    [No Abstract]   [Full Text] [Related]  

  • 9. [Glibornuride, a new high-effective antidiabetic agent. Pharmacological and biochemical comparative studies in various animal species and animal experimental models].
    Lorch E; Gey KF; Sommer P
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2154. PubMed ID: 4198964
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide).
    Loubatiéres A; Mariani MM; Ribes G; Alric R
    Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200675
    [No Abstract]   [Full Text] [Related]  

  • 11. [Biological properties of 1,2-benzisothiazole compounds. Hypoglycemic activity of some benzisothiazolylacylamidoethylbenzensulfonylureas].
    Amoretti L; Agosti A; Catellani PL
    Boll Soc Ital Biol Sper; 1971 May; 47(10):299-302. PubMed ID: 4999859
    [No Abstract]   [Full Text] [Related]  

  • 12. [Tolerance of high doses of a new oral antidiabetic drug].
    Heinze G
    MMW Munch Med Wochenschr; 1974 May; 116(21):1093-4. PubMed ID: 4209885
    [No Abstract]   [Full Text] [Related]  

  • 13. [Studies on long-term tolerance of glibornuride in the rat and in the dog].
    Schärer K; Heisler N; Sterner W
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2188. PubMed ID: 4679248
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effect of hypoglycemic sulfonylurea preparations on the heart conduction system].
    Pogátsa G; Németh M
    Orv Hetil; 1980 Sep; 121(37):2255-7. PubMed ID: 6780962
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute, subchronic and chronic toxicity of the new sulfonylurea glimepiride in rats.
    Donaubauer HH; Mayer D
    Arzneimittelforschung; 1993 May; 43(5):547-9. PubMed ID: 8328999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Action of the sulfonylureas tolbutamide and glypentide on the lacticdehydrogenase plasma levels (author's transl)].
    García-Rafanell J; Morell-Mestre J
    Rev Esp Fisiol; 1974 Jun; 30(2):91-6. PubMed ID: 4421448
    [No Abstract]   [Full Text] [Related]  

  • 17. Subchronic and chronic toxicity of the new sulfonylurea glimepiride in dogs.
    Schollmeier U; Brunk R; Mayer D
    Arzneimittelforschung; 1993 Oct; 43(10):1068-71. PubMed ID: 8267671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Extrapancreatic effects of sulfonylurea compounds. 3. Studies on the additional blood sugar decreasing and antilipolytic effect of tolbutamide, glibornuride, and glibenclamide on completely pancreatectomized dogs, chronically treated with insulin during acute experiment and following pretreatment with sulfonylurea compounds using small doses of sulfonylurea].
    Beyer J; Cordes U; Sell G; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2176. PubMed ID: 4198965
    [No Abstract]   [Full Text] [Related]  

  • 19. New oral antidiabetic drugs. Synthesis and structure-activity relationships.
    Francia E; Marin A; Verdejo F; Sanchez MS; Morell J
    Boll Chim Farm; 1975 Jul; 114(7):379-92. PubMed ID: 1164447
    [No Abstract]   [Full Text] [Related]  

  • 20. [Derivatives of pyrazole-l-carboxylic acid. VII. Synthesis and hypoglycemic properties of various N-(4-[2-(alkyl-2-pyrazoline-1-carbonamido)-ethyl]-benzenesulfonyl)-N'-cyclohexylurea].
    Brzozowski Z; Magiełka S; Wójcikowski C
    Acta Pol Pharm; 1983; 40(2):134-8. PubMed ID: 6659996
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.